You are here

Article info

Article menu

Download PDFPDF

Original article
Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology

Authors

  1. Correspondence to Dr Miklos Gulyas, Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala Se-75185, Sweden; miklos.gulyas{at}igp.uu.se
View Full Text

Citation

Gulyas M, Fillinger J, Kaposi AD, et al
Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology
Journal of Clinical Pathology 2019;72:529-535.

Publication history

  • Received December 8, 2018
  • Revised March 5, 2019
  • Accepted April 6, 2019
  • First published April 26, 2019.
Online issue publication 
June 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.